The regulation and function of CD20: an “enigma” of B-cell biology and targeted therapy
The introduction of anti-CD20 monoclonal antibodies such as rituximab, ofatumumab, or obinutuzumab improved the therapy of B-cell malignancies even though the precise physiological role and regulation of CD20 remains unclear. Furthermore, CD20 expression is highly variable between different B-cell m...
Saved in:
Published in | Haematologica (Roma) Vol. 105; no. 6; pp. 1494 - 1506 |
---|---|
Main Authors | , |
Format | Journal Article |
Language | English |
Published |
Italy
Ferrata Storti Foundation
01.06.2020
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!